FIGHTING BIOFILM TO SAVE LIMBS & LIVES
The Future of Infection Treatment
“The Biofilm Destroyer”
Sceptre is providing surgeons with the weapon of choice to combat implant infections.
*Patent Pending
Infections Are Extremely Costly for Patients & Healthcare Systems
26%
5-year mortality rate
HIGHER than 4 of the most common cancers
70,000+ US patients develop a joint infection each year.
$450k+
LIFETIME cost of implant-related infection
$2.2B+
COSTS to health care systems
